Company news
Nanjing Vazyme Biotech Co., Ltd. Class A (SSE:688105) news
Nanjing Vazyme Biotech Co., Ltd. Class A news releases on 6ix. Latest, Sep 25, 2026: "NANJING VAZYME BIOTECH CO., LTD."Announcement on Completion…
Press releases & updates
"NANJING VAZYME BIOTECH CO., LTD."Announcement on Completion of Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares and Results of Shareholding Reduction
September 24, 2026
"NANJING VAZYME BIOTECH CO., LTD."Notice on Convening the 2nd Extraordinary General Meeting in 2026
September 23, 2026
"NANJING VAZYME BIOTECH CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
August 27, 2026
Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth
August 26, 2026
"NANJING VAZYME BIOTECH CO., LTD."Indicative Announcement on Change in Equity Interests of a Shareholder Holding More Than 5% of Shares Reaching the 1% and 5% Thresholds and Disclosure of Simplified Report on Changes in Equity Interests
July 28, 2026
"NANJING VAZYME BIOTECH CO., LTD."Indicative Announcement on Progress of Shareholding Increase by the Controlling Shareholder and Equity Change Reaching the 1% Threshold
July 24, 2026
Announcement on the 1st Share Increase by Controlling Shareholder and Implementation Progress of the Share Increase Plan
June 22, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
June 8, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 25, 2026
Announcement on the Public Solicitation of Proxy Voting Rights by China Securities Small and Medium Investors Service Center Co., Ltd.
May 19, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
May 18, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 13, 2026
Announcement on Resolutions of the 22nd Meeting of the 2nd Board of Directors
April 22, 2026
Announcement on Implementation Result of Shares Repurchase and Share Changes
April 2, 2026
Announcement on Progress in Repurchasing Shares through Call Auction
March 2, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 26, 2026
Announcement on Estimated Daily Related Party Transactions in 2026
February 11, 2026
Earnings Preannouncement for 2025
January 29, 2026
Announcement on Expiration of Shareholding Reduction Plan and Results of Shareholders
December 24, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
December 22, 2025
Announcement on Voluntary Disclosure of Obtaining EU CE IVDR Certification for the Company's Products
December 17, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 5, 2025
Announcement on Election of Employee Director
November 20, 2025
Notice on the 2nd Extraordinary General Meeting in 2025
November 19, 2025
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
November 6, 2025
Announcement on By-election of Non-independent Director
October 29, 2025
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Subsidiary’s Product
September 24, 2025
Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
September 2, 2025
Announcement on Initially Repurchasing the Company's Shares through Call Auction
September 1, 2025
2025 Semi-annual Report
August 28, 2025
Announcement on Change of Sponsor Representative
June 27, 2025
Announcement on Plan for Repurchasing Shares through Call Auction
June 19, 2025
Indicative Announcement on the Proposal of Chairman, General Manager and Actual Controller to Repurchase Shares
June 17, 2025
Announcement on Voluntary Disclosure of Obtaining China Patent Excellent Award
June 8, 2025
Announcement on Voluntary Disclosure of Signing Strategic Cooperation Agreement and Proposed Establishment of Joint Venture
June 6, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 27, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 19, 2025
Announcement on Resolution of the 14th Meeting of the 2nd Board of Supervisors
April 28, 2025
Announcement on Renewing Engagement of Accounting Firm
April 9, 2025
Announcement on Change of Registered Capital, Amendment of Articles of Association, Completion of Industrial and Commercial Change Registration, and Renewal of Business License
March 21, 2025
Announcement on Voluntary Disclosure of Signing Strategic Cooperation Agreement
March 7, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 27, 2025
Announcement on Implementation Results of Share Repurchase and Share Changes
February 5, 2025
Announcement on Cancellation of Some Special Accounts for Raised Funds
January 20, 2025
Annual Earnings Preannouncement for 2024
January 16, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
December 30, 2024
Announcement on Canceling Repurchased Shares and Reducing Registered Capital and Notice to Creditors
December 20, 2024
Announcement on Adjusting the Total Cash Dividends for Profit Distribution in Q1-Q3 2024
December 15, 2024
Announcement on the Proposed Change in the Use of Partial Raised Funds and the Permanent Supplement of Working Capital with Partial Excess Raised Funds
December 12, 2024